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The sub-Saharan African (SSA) region is home to more than 230 million females of reproductive age who face multiple intersecting health, social, gender and economic challenges [1]. Neglected tropical diseases (NTDs) are a group of chronic disabling, almost exclusively communicable diseases affecting 
the poorest of the poor, especially in Africa, which alone bears about 40% of the global burden of NTDs [2-
4]. While both men and women are impacted, biological and sociocultural biases mean that NTDs dispro-
portionately affect women and girls [5]. In recent decades, there has been a global shift from communicable 
toward non-communicable diseases (NCDs), which cause almost 32 million deaths in low-and lower- mid-
dle-income countries (LMIC) [6]. It is expected that by 2030, 85% of NCD-related deaths among women will 
occur in LMICs, including many countries of SSA region [7]. For women older than 50, NCDs are the leading 
cause of both death and disability-adjusted life years (DALYs) [8]. Important disparities persist in access to 
maternal and reproductive health services both within and between countries in SSA [9]; it is estimated that 
almost half of the women in SSA do not have access to essential health care during pregnancy and childbirth. 
In 2017, SSA accounted for roughly two-thirds of all maternal deaths in the world [10]. Hence, it is evident 
that many, if not most, women and girls in SSA carry a triple burden of vulnerability to NTDs, NCDs and 
poor reproductive health outcomes. Here, we report on the outcomes of an integrative, multistakeholder work-
shop held in Gabon, Central Africa, to help develop a framework for synergistic, sustainable and gender- and 
context-appropriate interventions to manage the NTD-NCD complex and additionally reproductive health.
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Rationale for tracer conditions
This workshop identified female genital schistosomiasis (FGS), cesarean section (CS) and cervical cancer (CC) 
as tracer clinical conditions for the key themes of NTDs, NCDs and reproductive health respectively because 
they constitute major women’s health challenges in the SSA that demand collaborative solutions. Here we 
would like to highlight that while integrative solutions for the NTD-NCD complex have been attempted, we 
go one-step further to integrate reproductive health into our framework. The underlying reasoning was based 
on epidemiological data and gaps in knowledge outlined in brief as follows:
Female genital schistosomiasis (FGS)
Human schistosomiasis (bilharzia) is a parasitic disease prevalent in tropical areas with well-known clinical 
urinary an gastrointestinal tract manifestations. Female genital schistosomiasis (FGS) is a neglected and dis-
abling disease that results when eggs from the waterborne parasite Schistosoma haematobium are trapped in 
the human reproductive tract. Clinical manifestations include hypertrophic and ulcerative lesions of the vul-
va, vagina, and cervix, as well as grainy sandy patches, abnormal blood vessels, and rubbery papules on the 
cervix or vaginal wall. Infected females may suffer from symptoms mimicking sexually transmitted infections 
(STIs). Fresh water contact has been identified as an especial risk factor, hence, rural communities that rely 
on agriculture and fishing are especially at risk [11] Socio cultural factors in SSA increase the risk for devel-
oping urogenital schistosomiasis and thus FGS in women and girls eg, they are 2/3rds more likely than men 
to carry out water-based domestic and/or recreational activities [12]. The anti-helminthic drug Praziquantel 
(PZQ), is cheap, easily available, and effective in treating early infections [13]. The WHO recommends annual 
treatment with PZQ as a relatively affordable intervention, in highly endemic areas to treat schistosomiasis. 
Persistence of human papilloma virus (HPV), the causative agent for CC, has also been associated with FGS 
[14]. FGS has also been associated with horizontal transmission of HIV, rendering it a major cofactor in the 
AIDS epidemic [15]. FGS does not find a mention in most medical textbooks, or even in the lay media com-
pounding low awareness and poor diagnosis of the condition, among health workers [16]. Diagnosis usual-
ly requires facilities for colposcopy and histopathology, which are not widely available in endemic areas. In 
specialized gynecological or obstetric clinics, characteristic FGS lesions may not be attended to because of 
the lack of knowledge about the disease manifestations. In fact, health care providers have been reported 
to confuse the symptoms of FGS with those of STI or CC [17]. Out-of-pocket (OOP) cost for obtaining PZQ 
outside of school-based deworming and mass drug administration (MDA) programs is often prohibitive and 
results in low uptake by women [18]. Thus, obtaining accurate disease burden information, especially com-
munity-level burden assessment, is daunting, given that the clinical awareness is low, and diagnosis is com-
plex and cumbersome. Moreover, treatment is often inaccessible. Incorrect diagnosis and management can 
have profound psychosocial implications for sexually active girls. The effect of the disease on fertility and 
pregnancy have been reported to cause marginalization, stigma, isolation and the threat of gender-based vi-
olence (GBV) for women [19].
Cervical cancer (CC)
Research conducted over the past 30 years has established that HPV is the primary cause of cervical cancer. 
The majority of women become infected within a few years after becoming sexually active with HPV types 
16 and 18 causing about 70% of cases worldwide [20,21]. Infection rates for women tend to be high during 
their teens and 20s and about 10% of infected women develop precancerous lesions. If not detected through 
screening programs (and then treated), precancer develops into invasive cancer [22]. The lack of effective 
screening and treatment programs make CC a tracer disease of inequity and the inability to access adequate 
health care; about 90% of CC-related deaths occurring among women in LMICs and most in SSA [22]. The 
inequitable proportion of this health burden is expected to worsen, as global mortality rates in low-income 
countries will be nearly 27%, compared with only 1% in high-income countries [23]. HPV infection could 
effectively be prevented by vaccination. However, infrastructural weaknesses of the health systems in SSA 
prevent many girls and women from receiving the vaccine [24]. In fact, only six (Botswana, Lesotho, Rwan-
da, Senegal, South Africa and Uganda) out of 46 SSA countries have introduced national HPV immunization 
programs in any form [25,26]. A study of four West African countries showed that less than 1% of women 
have ever been screened [27]. In Gabon, CC ranks first in mortality for cancer in women and accounted for 
18% of all new cancers diagnosed in Gabonese women in 2018 [28]. Additionally, evidence suggests that 
HIV-HPV coinfection might lead to a more rapid transition from intra-epithelial lesions of the cervix to inva-
sive cancer [29-31]. The WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched in 
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of all three could reduce more than 40% of new cases of the disease and 5 million related deaths by 2050. 
While officially an NCD, the global outlook on CC is similar to that on NTDs: it is a disease of poverty and 
neglect, affecting poorer populations; has a disproportionately negative impact on female morbidity with en-
hanced stigma and discrimination; and can be managed and possibly eliminated through effective, feasible 
low-cost solutions [32].
Cesarean section (CS)
In 2017, SSA accounted for approximately 66% of the estimated global maternal deaths [33]. One evi-
dence-based intervention for reducing maternal morbidity and mortality is promoting institutional deliver-
ies, attended by a skilled birth attendant (SBA) and access to CS [34]. CS is a surgical procedure widely per-
formed to save maternal and fetal lives, preventing complications during labour and an important indicator 
of accessibility to emergency obstetric care [34]. The WHO considers CS rates of 10-15% to be the optimal 
range for this life saving interventions for mother and child [35]; in countries where at least 10% of women 
have CS, the number of preventable maternal and newborn deaths show a significant decrease [36]. The Afri-
can region has the lowest CS rate in the world and access to safe CS is estimated at only 1–2% in SSA [37,38]. 
Various studies from LMICs have identified a range of factors that contribute to sites where skilled care is 
available; women’s lower social status, education levels, lack of autonomy in decision-making and cultural 
norms that discourage the use of facility-based care [39-43, 44]. A poor formal referral system for identifying 
high-risk pregnancies has been recognized and established a need to target women earlier for professional 
intrapartum care [43,44]. A Medicins sans Frontiers (MSF) multi-country analysis conducted in SSA, report-
ed that the most common indications for CS were obstructed labor, malpresentation, history of prior CS, fe-
tal distress, uterine rupture, and antepartum hemorrhage [45]. Multiple studies conducted across Tanzania, 
Ethiopia and Burkina Faso found that suboptimal management occurred in many cases of CS and that there 
was a lack of awareness of evidence-based guidelines, leading to unnecessary CS [46-50]. Global CS rates are 
rising, but inconsistently so among and within countries of the SSA and mounting evidence suggests that CS 
may be utilized predominantly by wealthy urbanites [51-54]. While higher rates suggest improper selection 
of CS, lower rates suggest an unmet need. Thus, there is an overarching concern that access to and capacity 
of SSA to provide CS to those women for whom it is indicated, in all settings, is lacking.
Rationale for integrated, life course approach
There is growing evidence that NTDs endemic in SSA have chronic long-term complications that can develop 
into NCDs [55,56]. Disability arises due to delayed diagnosis and treatment, and/or because of disease com-
plications that are not well managed. Therefore, affected persons may end up with permanent impairments, 
including reduced intellectual development, which in turn may lead to functional limitations, barriers to so-
cial participation and reduced quality of life, social stigma and exclusion and chronic mental health prob-
lems [57,58]. Together, these problems incur an enormous economic and social cost to individuals, families 
and societies. There is also compelling evidence to suggest that many of the most prominent NTDs have suf-
ficient diagnostic tools and treatment currently available to eliminate them as severe public health problems 
[59]. Historically, ministries of health in disease-endemic countries have supported management through 
independent, often parallel, programs and integrating multiple interventions is considered costly [60]. With-
in SSA, the investment in management of morbidity and disability of all three conditions continues to lag be-
hind due to various factors: inadequately equipped health facilities, high human resource absenteeism rates, 
limited disease surveillance along with scarce laboratory diagnostic capacities, and insufficient government 
investment [61] which limit multi-sectoral and cross-sectoral collaborations and present challenges to a syn-
ergistic approach. In our approach we attempt to build upon existing NTD-NCD intervention frameworks 
to integrate reproductive health. The life course approach is an intuitive method to conceptualize integrat-
ed prevention and control for NCDs and NTDs by providing a comprehensive and sustainable framework 
to identify key interventions for improved health literacy and knowledge translation and a systems thinking 
approach [62]. An integrated approach also supports social justice and equity by provision of services that 
are coherent, uniform, and high quality, and enhances the motivation, skill, and competence of health care 
workers. This is reflected graphically in Figure 1.
METHODS
An integrative, multistakeholder workshop was organized in Gabon as an explorative method to investigate 
how such an approach across the three key themes (with the three tracer clinical conditions) could be mas-
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•  Explore the level of knowledge among health care providers and assess the care systems in place for 
combating the local burden of NTDs like FGS and NCDs like CC, with knowledge-sharing and prac-
tical teaching modules
•  Exchange comparative experiences and good practices for CS in the Gabonese context, with knowl-
edge-sharing and practical teaching modules
•  Identify opportunities for operational research collaboration between Europe and Gabon to enhance a 
systems-thinking approach for women’s health
The workshop was designed and developed by the HelmVit consortium (funded by the DFG, with additional 
assistance from the DZIF) to explore the effects of Schistosomiasis-associated pregnancy on vitamin D me-
tabolism. The coordination team was sited at the Technical University of Munich (TUM), Germany in close 
collaboration with partners at the University of Tübingen (UKT), Germany and Centre de Recherches Médi-
cales de Lambaréné (CERMEL), Gabon. An equitable representation of experts from from Europe (Germany, 
Switzerland and United Kingdom) and Africa (Gabon, Mozambique, Kenya and Cameroon) presented over 
the course of two-and-a half days. A detailed list of presenters is given in Appendix S1 in the Online Sup-
plementary Document. Presentations given by international experts included an overview of the global and 
local picture in Gabon about the three key themes through their tracer disease-conditions, the current avail-
able epidemiological data and disease burden and the gaps in knowledge and research. Four sessions of in-
depth plenaries covered the three key themes by lectures and open dialogue among participants via round 
tables and panel discussions. A general ‘women’s health’ plenary aimed to integrate expertise across the aca-
demic, community, industry and policy and governance spectrum. Two practical teaching modules allowed 
hands-on training for midwives, nurses and gynaecologists, and introduced innovative digital health appli-
cations for field diagnosis and awareness generation. A further collaborative session allowed all participants 
to generate reflections for knowledge exchange. A detailed agenda is reproduced in Appendix S2 in the On-
line Supplementary Document. The workshop was run in English to facilitate the full compendium of par-
ticipants and researchers from diverse language backgrounds and contexts. However, since the operational 
language of the nurses and midwives was French, English-to-French translation facilitators were on hand for 
support. All English presentations were pre-translated into French and distributed as handouts to all partici-
pants. During the round-table sessions, in which participants discussed competencies, both French and En-
glish were supported options. The coordination team recorded all sessions in documentary and video format.
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RESULTS
Outcome of interactive sessions
The interactive sessions instigated cross-sectoral and interdisciplinary communication to achieve three dis-
tinct outcomes: (1) To understand barriers and enablers for diagnosis, management and care of NCDs, NTDs 
and reproductive health conditions in the context of Gabon; (2) To instigate stakeholder engagement to ex-
plore potential mutual leverage within the interests and capacities of stakeholders; (3) To develop an integra-
tive framework for sustainable, gender and context appropriate interventions, including identifying gaps in 
research (see below). We have summarized a conceptual and interventional framework for an integrated ap-
proach to the three key themes in Figure 2.
Figure 2. Conceptual and interventional framework for an integrated approach for management of FGS, CS and CC.
Knowledge sharing and capacity building via practical modules
The workshop also introduced hands-on training module on various modes of vaginal delivery using birth 
models; and novel point-of-care (POC) screening and diagnostic schemes piloted in Zambia: a portable col-
poscope with image analysis via integrated mobile app and possibility to integrate CC/FGS diagnosis via di-
agnosis from remote specialists. The content of all training modules is presented in Table 1.
Table 1. Training content for practical modules
FGS Cervical Cancer (CC) Cesarean Section (CS)
− Innovations in digital health for diagnostics
Practical Module − Portable colposcope with image analysis
−  Hands-on training session with delivery model eg, management 
of shoulder dystocia, vaginal vacuum extraction and breech pre-
sentation delivery
− Hands-on training session with models
Knowledge  
Sharing
−  Videos: Cervical self-swabbing, challenges in the field, learnings 
from Zambia BILHIV* study
−  Videos: Performance of ‘normal’ CS using Misgav-Ladach meth-
od and ‘difficult’ CS with reverse breech extraction
−  Introduction of integrated cervical cancer/FGS diagnostics via 
m-health
−  Video demonstration for birth maneuvers
FGS – female genital schistosomiasis
*The BILHIV study is a cooperation between LSHTM, University of Zambia and collaborators from Leiden Medical Center, Oslo University, the Natural 
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Operational research inventory
The operational research needs highlighted during the workshop included: (i) community-level burden as-
sessment of FGS and CC in Gabon (ii) strategies to improve community engagement with FGS to facilitate 
behavioural change (iii) clinical treatment protocols and integrated management for FGS and CC – program-
matic alignment within the Pink October (‘Octobre Rose’) (A public health campaign by the Sylvia Bongo 
Foundation, Gabon aimed at strengthening awareness-raising actions, prevention and detection for female 
cancers) campaign in Gabon (iv) identify best strategies to ensure access to safe, affordable and accessible 
PZQ for women and girls outside of school-based deworming and MDA (v) adaptation of partograms for CS 
to local contexts and infrastructure (vi) establish evidence base for the success of task-shifting to optimize 
resources eg, midwives and nurses to implement HPV vaccination and FGS-CC screening programs. These 
operational research needs are envisioned as contributing to an ‘Inventory of Knowledge Gaps and Research 
Questions for Women’s Health in SSA’ as a living document. As the life-course approach establishes, wom-
en’s health needs change during the various stages of their lives hence there is a continuous need for age and 
sex disaggregated data to monitor women’s health status across age categories.
The future of integrated programmatic approaches in the context of COVID-19
The COVID-19 pandemic represents one of the most challenging global public health emergencies in almost 
a century. The repurposing of health care staff for the pandemic response has created challenges for the NTD, 
NCD and reproductive health programs in many countries [63,64]. Hence, while the gains made before the 
COVID-19 pandemic can cushion recurrence and rebound for many tracer disease-conditions, the impact 
of the pandemic could be devastating in the long term, if not addressed appropriately. Integration of the 
COVID-19 response, and indeed further emergencies, into existing control and elimination strategies for the 
three key themes is the need of the hour. As a first step, the capacity of integrated NTD-NCD-reproductive 
health programs could be leveraged to convey outbreak-related messages and interventions in hard-to-reach 
populations [65]. Existing health care infrastructure could be used for mapping preventive chemotherapy 
diseases and delivering drugs for both NTDs and outbreaks of novel diseaes [66,67]. Alternative strategies to 
support high-risk groups with existing NCDs and provision of selected sexual and reproductive health and 
rights (SRHR) services through telemedicine (advice by telephone or online means) to replace in-person con-
sultations have already reported some success [64]; SMS-based systems can be used for parallel reporting of 
COVID-19 testing along with diagnostics and/or and follow-up of NTDs, NCDs and reproductive health ser-
vices in endemic regions [68]. The scaling-back of non-COVID-19-related health and social services in SSA 
meant the major brunt fell on women as the default family caregivers and the majority of front-line health 
workers, especially nurses and midwives [69,70]. Women’s socially prescribed care roles typically place them 
in a prime position to identify trends in the ebb and flow of an outbreak; thus incorporating women’s voices 
and knowledge could be empowering and improve emergency preparedness and response. The momentum 
on control and management of COVID-19 should be leveraged to inform the development of integrated pro-
grammatic approaches. This will allow us to raise the profile of the disease-conditions that affect the world’s 
most poor and marginalized while the global human population is highly sensitized to a public health crisis 
of mass proportions.
CONCLUSION
There is compelling evidence to suggest that women and girls in SSA carry a triple burden of vulnerability 
to NTDs, NCDs and poor reproductive health outcomes and that controlling for one may positively affect 
the outcomes for the other two. The current global health environment demands efficient, multidisciplinary, 
gender-sensitive and rights-based approaches to address the intersecting health, gender and economic issues 
facing women and girls throughout their life course. Hence, an integrative, multistakeholder workshop took 
up FGS, CC and CS as tracer disease-conditions, that impact woman’s health throughout their life course, to 
develop a framework for synergistic, sustainable and gender- and context-appropriate interventions to man-
age the NTD-NCD complex and additionally reproductive health. The overarching aim was 2-fold: to con-
textualize the interventional overlap of NCDs and NTDs for management, and scale-up this approach to in-
clude SRHR issues affecting girls and women in SSA; and to highlight how programmatic integration of all 
the key themes could enhance efficiencies of service delivery and better use of limited resources. Such an 
effort, while contributing to better health outcome in the region, also help accelerating the contribution to 
improving women’s health through the adoption of the SDG3, SDG5 and SDG10; on health and well-being, 
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